Literature DB >> 23733801

Trends in bronchiolitis hospitalizations in the United States, 2000-2009.

Kohei Hasegawa1, Yusuke Tsugawa, David F M Brown, Jonathan M Mansbach, Carlos A Camargo.   

Abstract

OBJECTIVE: To examine temporal trend in the national incidence of bronchiolitis hospitalizations, use of mechanical ventilation, and hospital charges between 2000 and 2009.
METHODS: We performed a serial, cross-sectional analysis of a nationally representative sample of children hospitalized with bronchiolitis. The Kids Inpatient Database was used to identify children <2 years of age with bronchiolitis by International Classification of Diseases, Ninth Revision, Clinical Modification code 466.1. Primary outcome measures were incidence of bronchiolitis hospitalizations, mechanical ventilation (noninvasive or invasive) use, and hospital charges. Temporal trends were evaluated accounting for sampling weights.
RESULTS: The 4 separated years (2000, 2003, 2006, and 2009) of national discharge data included 544 828 weighted discharges with bronchiolitis. Between 2000 and 2009, the incidence of bronchiolitis hospitalization decreased from 17.9 to 14.9 per 1000 person-years among all US children aged <2 years (17% decrease; P(trend) < .001). By contrast, there was an increase in children with high-risk medical conditions (5.9%-7.9%; 34% increase; P(trend) < .001) and use of mechanical ventilation (1.9%-2.3%; 21% increase; P(trend) = .008). Nationwide hospital charges increased from $1.34 billion to $1.73 billion (30% increase; P(trend) < .001); this increase was driven by a rise in the geometric mean of hospital charges per case from $6380 to $8530 (34% increase; P(trend) < .001).
CONCLUSIONS: Between 2000 and 2009, we found a significant decline in bronchiolitis hospitalizations among US children. By contrast, use of mechanical ventilation and hospital charges for bronchiolitis significantly increased over this same period.

Entities:  

Keywords:  bronchiolitis; hospital charge; hospitalization; incidence; mortality; trends

Mesh:

Year:  2013        PMID: 23733801      PMCID: PMC3691534          DOI: 10.1542/peds.2012-3877

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  32 in total

1.  Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis.

Authors:  Carla G García; Rafia Bhore; Alejandra Soriano-Fallas; Margaret Trost; Rebecca Chason; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

2.  Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.

Authors:  Lauren J Stockman; Aaron T Curns; Larry J Anderson; Gayle Fischer-Langley
Journal:  Pediatr Infect Dis J       Date:  2012-01       Impact factor: 2.129

Review 3.  The regionalization of pediatric health care.

Authors:  Scott A Lorch; Sage Myers; Brendan Carr
Journal:  Pediatrics       Date:  2010-11-01       Impact factor: 7.124

4.  Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Stephen J Teach; Ashley F Sullivan; Tate Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Arch Pediatr Adolesc Med       Date:  2012-08

5.  Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007.

Authors:  Tara Lagu; Michael B Rothberg; Meng-Shiou Shieh; Penelope S Pekow; Jay S Steingrub; Peter K Lindenauer
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

6.  Children with complex chronic conditions in inpatient hospital settings in the United States.

Authors:  Tamara D Simon; Jay Berry; Chris Feudtner; Bryan L Stone; Xiaoming Sheng; Susan L Bratton; J Michael Dean; Rajendu Srivastava
Journal:  Pediatrics       Date:  2010-09-20       Impact factor: 7.124

7.  Increase in use of non-invasive ventilation for infants with severe bronchiolitis is associated with decline in intubation rates over a decade.

Authors:  Subodh Suhas Ganu; Anil Gautam; Barry Wilkins; Jonathan Egan
Journal:  Intensive Care Med       Date:  2012-04-18       Impact factor: 17.440

8.  Respiratory symptoms and the case definition of gastroenteritis: an international analysis of the potential impact on burden estimates.

Authors:  G Hall; L McDonald; S E Majowicz; E Scallan; M Kirk; P Sockett; F J Angulo
Journal:  Epidemiol Infect       Date:  2009-06-04       Impact factor: 2.451

9.  Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Michelle D Stevenson; Ashley F Sullivan; Tate F Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Pediatrics       Date:  2012-08-06       Impact factor: 7.124

Review 10.  Bronchiolitis: recent evidence on diagnosis and management.

Authors:  Joseph J Zorc; Caroline Breese Hall
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

View more
  139 in total

1.  Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity.

Authors:  K Hasegawa; C J Stewart; J C Celedón; J M Mansbach; C Tierney; C A Camargo
Journal:  Allergy       Date:  2018-02-05       Impact factor: 13.146

2.  Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Yury A Bochkov; James E Gern; Pedro A Piedra; Cindy S Bauer; Stephen J Teach; Susan Wu; Ashley F Sullivan; Carlos A Camargo
Journal:  JAMA Pediatr       Date:  2019-06-01       Impact factor: 16.193

3.  Serum Metabolome Is Associated With the Nasopharyngeal Microbiota and Disease Severity Among Infants With Bronchiolitis.

Authors:  Christopher J Stewart; Jonathan M Mansbach; Nadim J Ajami; Joseph F Petrosino; Zhaozhong Zhu; Liming Liang; Carlos A Camargo; Kohei Hasegawa
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

4.  The Fecal Microbiota Profile and Bronchiolitis in Infants.

Authors:  Kohei Hasegawa; Rachel W Linnemann; Jonathan M Mansbach; Nadim J Ajami; Janice A Espinola; Joseph F Petrosino; Pedro A Piedra; Michelle D Stevenson; Ashley F Sullivan; Amy D Thompson; Carlos A Camargo
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

5.  Discharge Criteria for Bronchiolitis: An Unmet Need.

Authors:  Cristina Garcia-Mauriño; Melissa Moore-Clingenpeel; Rebecca Wallihan; Katalin Koranyi; Bavani Rajah; Tiffany Shirk; Maria Vegh; Octavio Ramilo; Asuncion Mejias
Journal:  Pediatr Infect Dis J       Date:  2018-06       Impact factor: 2.129

6.  Point-of-care lung ultrasound in infants with bronchiolitis in the pediatric emergency department: a prospective study.

Authors:  Maria Chiara Supino; Danilo Buonsenso; Simona Scateni; Barbara Scialanga; Maria Alessia Mesturino; Caterina Bock; Antonio Chiaretti; Emanuele Giglioni; Antonino Reale; Anna Maria Musolino
Journal:  Eur J Pediatr       Date:  2019-02-12       Impact factor: 3.183

7.  Intermittent Pulse Oximetry Use and Length of Stay in Bronchiolitis: Bystander or Primary Driver?

Authors:  Jason Burrows; Kathleen Berg; Russell McCulloh
Journal:  Hosp Pediatr       Date:  2019-01-03

8.  Respiratory syncytial virus-associated mortality in hospitalized infants and young children.

Authors:  Carrie L Byington; Jacob Wilkes; Kent Korgenski; Xiaoming Sheng
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

9.  Factors Associated With Asthma Diagnosis Within Five Years of a Bronchiolitis Hospitalization: A Retrospective Cohort Study in a High Asthma Prevalence Population.

Authors:  Amanda J Clark; Nancy Dong; Talia Roth; Lindsey C Douglas
Journal:  Hosp Pediatr       Date:  2019-10

Review 10.  Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches.

Authors:  Kohei Hasegawa; Orianne Dumas; Tina V Hartert; Carlos A Camargo
Journal:  Expert Rev Respir Med       Date:  2016-06-16       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.